Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
3.410
+0.280 (8.95%)
Oct 19, 2026, 3:10 PM EDT - Market open
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $149.67 million as of October 19, 2026. It is the 23,171st most valuable company in the world and the 3,860th biggest in the United States. Its market cap has decreased by 88.24% in one year.
Market Cap
149.67M
Enterprise Value
137.77M
1-Year Change
-88.24%
Global Rank
Country Rank
#3,860 United States
Category
ChartMarket Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has decreased from $219.46M to $149.67M, a decrease of -31.80%. That is a compound annual growth rate of -20.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 149.67M | -88.66% |
| Dec 31, 2025 | 1.32B | 501.40% |
| Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AngioDynamics | 472.69M |
| Embecta | 355.26M |
| Sanara MedTech | 304.68M |
| OraSure Technologies | 248.98M |
| Utah Medical Products | 237.23M |
| Pro-Dex | 186.63M |
| Jin Medical International | 163.15M |
| KORU Medical Systems | 138.52M |